Cargando…
SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514341/ https://www.ncbi.nlm.nih.gov/pubmed/34655528 http://dx.doi.org/10.1016/S2468-1253(21)00347-2 |
_version_ | 1784583360718307328 |
---|---|
author | Selim, Rania Wellens, Judith Marlow, Luke Satsangi, Jack J |
author_facet | Selim, Rania Wellens, Judith Marlow, Luke Satsangi, Jack J |
author_sort | Selim, Rania |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8514341 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85143412021-10-14 SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy Selim, Rania Wellens, Judith Marlow, Luke Satsangi, Jack J Lancet Gastroenterol Hepatol Correspondence Elsevier Ltd. 2021-12 2021-10-14 /pmc/articles/PMC8514341/ /pubmed/34655528 http://dx.doi.org/10.1016/S2468-1253(21)00347-2 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence Selim, Rania Wellens, Judith Marlow, Luke Satsangi, Jack J SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy |
title | SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy |
title_full | SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy |
title_fullStr | SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy |
title_full_unstemmed | SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy |
title_short | SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy |
title_sort | sars-cov-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514341/ https://www.ncbi.nlm.nih.gov/pubmed/34655528 http://dx.doi.org/10.1016/S2468-1253(21)00347-2 |
work_keys_str_mv | AT selimrania sarscov2vaccinationuptakebypatientswithinflammatoryboweldiseaseonbiologicaltherapy AT wellensjudith sarscov2vaccinationuptakebypatientswithinflammatoryboweldiseaseonbiologicaltherapy AT marlowluke sarscov2vaccinationuptakebypatientswithinflammatoryboweldiseaseonbiologicaltherapy AT satsangijackj sarscov2vaccinationuptakebypatientswithinflammatoryboweldiseaseonbiologicaltherapy |